Evidence map›Paper›PMID 38096417›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Antimicrobial resistance level and conjugation permissiveness shape plasmid distribution in clinical enterobacteria.

Aida Alonso-Del Valle, Laura Toribio-Celestino, Anna Quirant, Carles Tardio Pi, Javier DelaFuente, Rafael Canton, Eduardo P C Rocha, Carles Ubeda, Rafael Peña-Miller, Alvaro San Millan

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Characterization of Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Aida Alonso-Del Valle *Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Madrid 28049, Spain.
Laura Toribio-Celestino *Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Madrid 28049, Spain.
Anna QuirantFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Valencia 46020, Spain.
Carles Tardio PiCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca 62209, México.ORCID 0000-0003-1794-799X
Javier DelaFuenteCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Madrid 28049, Spain.
Rafael CantonServicio de Microbiología, Hospital Universitario Ramón y Cajal-Instituto Ramon y Cajal de Investigacion Sanitaria, Madrid 28034, Spain.ORCID 0000-0003-1675-3173
Eduardo P C RochaInstitut Pasteur, Université de Paris Cité, CNRS UMR3525, Microbial Evolutionary Genomics, Paris 75015, France.ORCID 0000-0001-7704-822X
Carles UbedaFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Valencia 46020, Spain.
Rafael Peña-MillerCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca 62209, México.ORCID 0000-0002-2767-0640
Alvaro San MillanCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Madrid 28049, Spain.ORCID 0000-0001-8544-0387
Consejo Superior de Investigaciones Científicas · ESInstituto de Salud Carlos III · ESUniversidad Nacional Autónoma de México · MXCentre National de la Recherche Scientifique · FRFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ES

Funding

Consejo Nacional de Ciencia y Tecnología (CONACYT) 2019-217367Consejo Nacional de Ciencia y Tecnología (CONACYT) A1-S-321649EC | European Research Council (ERC) 757440MEC | Instituto de Salud Carlos III (ISCIII) PI19/00749Ministerio de Ciencia e Innovación (MCIN) PID2020-120292RB-I00
6 · The paper itself

Abstract

Conjugative plasmids play a key role in the dissemination of antimicrobial resistance (AMR) genes across bacterial pathogens. AMR plasmids are widespread in clinical settings, but their distribution is not random, and certain associations between plasmids and bacterial clones are particularly successful. For example, the globally spread carbapenem resistance plasmid pOXA-48 can use a wide range of enterobacterial species as hosts, but it is usually associated with a small number of specific

Indexed as

Anti-Bacterial AgentsPermissivenessBacteriaDrug Resistance, BacterialEscherichia coliHumansKlebsiellaKlebsiella pneumoniaePlasmidsAnti-Bacterial Agentsantimicrobial resistancebacteriamobile genetic elementsplasmid

Identifiers

PMID38096417
PMCPMC10741383
OpenAlexW4389722462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.